Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $157,395.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 10,500 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total value of $157,395.00. Following the completion of the sale, the insider now owns 309,944 shares of the company’s stock, valued at approximately $4,646,060.56. This represents a 3.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hakan Kardes also recently made the following trade(s):

• On Friday, January 24th, Hakan Kardes sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.98, for a total value of $217,210.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.06, for a total transaction of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total transaction of $58,410.00.

Alignment Healthcare Price Performance

ALHC opened at $14.97 on Friday. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $15.05. The firm has a 50-day moving average of $12.13 and a 200 day moving average of $11.02. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market cap of $2.87 billion, a P/E ratio of -19.44 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.14). The firm had revenue of $692.43 million during the quarter, compared to the consensus estimate of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company’s revenue was up 51.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.19) EPS. On average, research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Trading of Alignment Healthcare

Several hedge funds have recently made changes to their positions in ALHC. Creative Planning increased its holdings in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after acquiring an additional 2,072 shares during the last quarter. R Squared Ltd purchased a new position in shares of Alignment Healthcare in the fourth quarter worth about $55,000. SG Americas Securities LLC raised its position in shares of Alignment Healthcare by 11.7% in the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company’s stock valued at $554,000 after purchasing an additional 5,163 shares during the period. nVerses Capital LLC bought a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $95,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock worth $434,000 after buying an additional 9,595 shares during the period. 86.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Barclays upped their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. UBS Group lifted their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Stifel Nicolaus increased their price target on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Stephens reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 2nd. Finally, KeyCorp began coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $11.88.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.